Doctors in Taiwan have cited concerns over costs, testing delays, and potential interactions for the low prescription of oral COVID-19 drugs, which have only been used to treat just over 3,000 people despite daily case numbers surpassing 50,000.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
Exotic pets in Taiwan will need registration, owner approval: MOA
09/03/2025 10:24 PM - Science & Tech
Taiwan signs MOU on drone cooperation with Poland, Ukraine
09/03/2025 09:52 PM - Politics
China should stop illegal drilling near Pratas Island: Presidential Office
09/03/2025 09:36 PM - Business
Taiwan, Japan to launch cross border ETF listings this month
09/03/2025 09:24 PM - Cross-Strait
DPP slams China, Russia parades as threat to peace
09/03/2025 09:03 PM